Open Access. Powered by Scholars. Published by Universities.®
Medicinal and Pharmaceutical Chemistry Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Anatomy (1)
- Biology (1)
- Cancer Biology (1)
- Cell Anatomy (1)
- Cell Biology (1)
-
- Cell and Developmental Biology (1)
- Chemistry (1)
- Life Sciences (1)
- Medical Cell Biology (1)
- Medical Neurobiology (1)
- Medical Sciences (1)
- Medical Specialties (1)
- Medical Toxicology (1)
- Medicinal Chemistry and Pharmaceutics (1)
- Nervous System (1)
- Neurology (1)
- Neuroscience and Neurobiology (1)
- Neurosciences (1)
- Pharmacology, Toxicology and Environmental Health (1)
- Physical Sciences and Mathematics (1)
- Toxicology (1)
- Publication Type
Articles 1 - 2 of 2
Full-Text Articles in Medicinal and Pharmaceutical Chemistry
The Effects Of Paclitaxel On Cellular Migration And The Cytoskeleton, Ashley Salguero-Gonzalez
The Effects Of Paclitaxel On Cellular Migration And The Cytoskeleton, Ashley Salguero-Gonzalez
Thinking Matters Symposium
In a clinical setting, some patients are exposed to an anti-cancer chemotherapy agent, paclitaxel. Cancerous cells undergo rapid, continuous cell division without control. Chemotherapy treatments try to slow and stop the uncontrollable cell division cycles and eliminate cancerous cells in the process. Paclitaxel serves as a treatment for some types of cancers, including lung, melanoma, bladder, and esophageal. Because it targets the cytoskeleton, paclitaxel can also influence cell migration. This project utilizes a cellular migration assay and an immunohistochemistry assay to analyze the effects of paclitaxel on the movement of cells and on the cytoskeleton of neuroglia rat cells with …
Optimization Of The Structure Of Ttr Ligands For Half-Life Extension (Tlhe), Guanming Jiang
Optimization Of The Structure Of Ttr Ligands For Half-Life Extension (Tlhe), Guanming Jiang
University of the Pacific Theses and Dissertations
Many potential therapeutic agents face challenges for their clinical development due to short circulation half-life. As a result, prolonging the half-life of therapeutic drugs in circulation while preserving their hydrophilicity and small size will be a key step toward more effective and safe pharmacological molecules. Our lab developed a new approach for enhancing the safety and efficacy of therapeutic agents. By endowing therapeutic agents with a hydrophilic small molecule (a derivative of the clinical candidate, AG10) which reversibly binds to the serum protein transthyretin (TTR), the half-life of the therapeutic agent should be extended by binding to the TTR in …